Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

The Lancet Oncology ◽

10.1016/s1470-2045(09)70222-0 ◽

2009 ◽

Vol 10 (10) ◽

pp. 967-974 ◽

Author(s):

Youjin Je ◽

Fabio AB Schutz ◽

Toni K Choueiri

Keyword(s):

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Risk Of Bleeding ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

PLoS ONE ◽

10.1371/journal.pone.0090135 ◽

2014 ◽

Vol 9 (3) ◽

pp. e90135 ◽

Author(s):

Ze-Feng Zhang ◽

Tao Wang ◽

Li-Hua Liu ◽

Hui-Qin Guo

Keyword(s):

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2017.09.016 ◽

2017 ◽

Vol 119 ◽

pp. 50-58 ◽

Author(s):

Jing Li ◽

Jian Gu

Keyword(s):

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Hand Foot Skin Reaction ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: A systematic review and meta-analysis

Molecular and Clinical Oncology ◽

10.3892/mco.2015.572 ◽

2015 ◽

Vol 3 (4) ◽

pp. 959-967 ◽

Author(s):

ZEXIN LIN ◽

YILIN YANG ◽

YONGLIANG HUANG ◽

JUNJIE LIANG ◽

FANG LU ◽

...

Keyword(s):

Colorectal Cancer ◽

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2013.10.002 ◽

2014 ◽

Vol 89 (3) ◽

pp. 394-403 ◽

Author(s):

Wei-Xiang Qi ◽

Yuan-Jue Sun ◽

Li-Na Tang ◽

Zan Shen ◽

Yang Yao

Keyword(s):

Systematic Review ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials

European Journal of Clinical Pharmacology ◽

10.1007/s00228-017-2299-y ◽

2017 ◽

Vol 73 (10) ◽

pp. 1209-1217 ◽

Author(s):

Jing Li ◽

Jian Gu

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: An up-to-date meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2014.04.004 ◽

2014 ◽

Vol 92 (2) ◽

pp. 71-82 ◽

Author(s):

Wei-Xiang Qi ◽

Zan Shen ◽

Li-Na Tang ◽

Yang Yao

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Thromboembolic Events ◽

Arterial Thromboembolic Events ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis

OncoTargets and Therapy ◽

10.2147/ott.s87298 ◽

2015 ◽

pp. 2361 ◽

Author(s):

Dian-Sheng Zhong ◽

Qing Ma ◽

Li-Yan Gu ◽

Yao-Yao Ren ◽

Li-Li Zeng ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Increased Risk ◽

Severe Infections ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Faculty Opinions recommendation of Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733648682.793548437 ◽

2018 ◽

Author(s):

Camilo Jimenez

Keyword(s):

Vascular Endothelial Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Fatigue associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis

International Journal of Clinical Oncology ◽

10.1007/s10147-017-1167-1 ◽

2017 ◽

Vol 22 (5) ◽

pp. 807-816 ◽

Author(s):

Jing Li ◽

Jian Gu

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Cancer Patients ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2014.11.006 ◽

2015 ◽

Vol 93 (3) ◽

pp. 257-276 ◽

Author(s):

Pooja Ghatalia ◽

Youjin Je ◽

Nemer El Mouallem ◽

Paul L. Nguyen ◽

Quoc-Dien Trinh ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Clinical Trials ◽

Receptor Tyrosine Kinase ◽

Randomized Clinical Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text